監修者の紹介｜ムジア・クタテラーゼ（Mzia Kutateladze）先生
ムジア・クタテラーゼ（Mzia Kutateladze）先生
エリアヴァ研究所所長
経歴
エリアヴァ研究所所長、同研究所学術委員会議長、同分子生物学研究室室長、トビリシ国立大学生物学部卒業。さまざまなバクテリオファージの感染症治療薬を研究し、米国国防脅威削減局の基金によるバクテリオファージ研究など、さまざまな国際プロジェクトに参加している。論文
Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study.
Nature Microbiology 9(6):1434–1453 (2024).
Publisher
·
Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae.
Nature Communications 13:302 (2022).
Publisher
·
Indexed (Europe PMC)
Bacteriophages as potential new therapeutics to replace or supplement antibiotics.
Trends in Biotechnology 28(12):591–595 (2010).
Publisher (Cell/Elsevier)
·
Indexed (Europe PMC)
Phage therapy experience at the Eliava Institute.
Médecine et Maladies Infectieuses 38(8):426–430 (2008).
Full text (shared)
·
Indexed (record)
Eradication of a Multidrug-Resistant, Carbapenemase-Producing Klebsiella pneumoniae Isolate Following Oral and Intra-rectal Therapy With a Custom Made, Lytic Bacteriophage Preparation.
Clinical Infectious Diseases 70(9):1998–2001 (2020).
Publisher
·
Indexed (Europe PMC)
Bacteriophage treatment of intransigent diabetic toe ulcers: a case series.
Journal of Wound Care 25(Sup7):S27–S33 (2016).
Record (CoLab)
·
Shared PDF
Phylogeny of the major head and tail genes of the wide-ranging T4-type bacteriophages.
Journal of Bacteriology 183(1):358–366 (2001).
Record (Google Scholar)
Bacteriophage therapy in implant-related infections: an experimental study.
The Journal of Bone and Joint Surgery 95(2):117–125 (2013).
Record (Google Scholar)
Evaluation of lytic activity of staphylococcal bacteriophage Sb‑1 against freshly isolated clinical pathogens.
Microbial Biotechnology 4(5):643–650 (2011).
Record (Google Scholar)
Phage therapy in a 16‑year‑old boy with Netherton syndrome.
Frontiers in Medicine 4:94 (2017).
Record (Google Scholar)
